C G Fraser

555 total citations
16 papers, 447 citations indexed

About

C G Fraser is a scholar working on Physiology, Statistics, Probability and Uncertainty and Molecular Biology. According to data from OpenAlex, C G Fraser has authored 16 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Statistics, Probability and Uncertainty and 4 papers in Molecular Biology. Recurrent topics in C G Fraser's work include Clinical Laboratory Practices and Quality Control (7 papers), Statistical Methods in Clinical Trials (4 papers) and Meta-analysis and systematic reviews (3 papers). C G Fraser is often cited by papers focused on Clinical Laboratory Practices and Quality Control (7 papers), Statistical Methods in Clinical Trials (4 papers) and Meta-analysis and systematic reviews (3 papers). C G Fraser collaborates with scholars based in United Kingdom, Australia and United States. C G Fraser's co-authors include P H Petersen, M C Browning, Samuel J. Callaghan, Paul Mitchell, Alison Severn, Rajeev Srivastava, Ali Jahan, Michael J. Murphy, F Bonńici and Michael Emmett and has published in prestigious journals such as The Lancet, Clinical Chemistry and Journal of Clinical Pathology.

In The Last Decade

C G Fraser

16 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C G Fraser United Kingdom 9 257 122 94 61 53 16 447
Paul Janson Netherlands 9 140 0.5× 50 0.4× 34 0.4× 28 0.5× 58 1.1× 18 405
Marta Stahl Denmark 12 152 0.6× 81 0.7× 97 1.0× 28 0.5× 41 0.8× 20 353
Gunn B.B. Kristensen Denmark 11 385 1.5× 225 1.8× 27 0.3× 28 0.5× 76 1.4× 13 500
David J. Hassemer United States 14 159 0.6× 58 0.5× 61 0.6× 34 0.6× 53 1.0× 26 688
Anne Stavelin Norway 13 207 0.8× 124 1.0× 41 0.4× 49 0.8× 66 1.2× 34 335
Marijana Miler Croatia 12 149 0.6× 68 0.6× 27 0.3× 16 0.3× 42 0.8× 44 408
Francisco A. Bernabéu-Andréu Spain 12 125 0.5× 69 0.6× 31 0.3× 30 0.5× 40 0.8× 31 307
Solveig Linko Finland 11 93 0.4× 50 0.4× 50 0.5× 30 0.5× 36 0.7× 18 279
Lara Milevoj Kopčinović Croatia 12 95 0.4× 33 0.3× 50 0.5× 7 0.1× 34 0.6× 28 301
C. Markus Australia 10 116 0.5× 88 0.7× 9 0.1× 56 0.9× 35 0.7× 43 283

Countries citing papers authored by C G Fraser

Since Specialization
Citations

This map shows the geographic impact of C G Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C G Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C G Fraser more than expected).

Fields of papers citing papers by C G Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C G Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C G Fraser. The network helps show where C G Fraser may publish in the future.

Co-authorship network of co-authors of C G Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of C G Fraser. A scholar is included among the top collaborators of C G Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C G Fraser. C G Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Srivastava, Rajeev, et al.. (2004). The case of the floating gel: Figure 1. Journal of Clinical Pathology. 57(12). 1333–1334. 8 indexed citations
2.
Fraser, C G & P H Petersen. (1995). Desirable performance standards for imprecision and bias in alternate sites. The views of laboratory professionals.. PubMed. 119(10). 909–13. 15 indexed citations
3.
Fraser, C G & P H Petersen. (1993). Desirable standards for laboratory tests if they are to fulfill medical needs. Clinical Chemistry. 39(7). 1447–1455. 86 indexed citations
4.
Fraser, C G. (1990). Quality Specifications in Laboratory Medicine. Upsala Journal of Medical Sciences. 95(3). 229–232. 8 indexed citations
5.
Mitchell, Paul, et al.. (1990). A Case of Heavy Chain Disease: Diagnosis and Monitoring Using Assays of Immunoglobulin Heavy and Light Chains. Scottish Medical Journal. 35(1). 18–19. 1 indexed citations
6.
Fraser, C G, et al.. (1990). Setting analytical goals for random analytical error in specific clinical monitoring situations. Clinical Chemistry. 36(9). 1625–1628. 89 indexed citations
7.
Fraser, C G, et al.. (1989). Biological variation of urinary N-acetyl-beta-D-glucosaminidase: practical and clinical implications.. Clinical Chemistry. 35(4). 560–563. 9 indexed citations
8.
Jahan, Ali, M C Browning, & C G Fraser. (1988). Desirable performance standards for assays of serum water and osmolality.. Clinical Chemistry. 34(5). 995–995. 7 indexed citations
9.
Mitchell, Paul, et al.. (1988). Desirable performance characteristics and clinical utility of immunoglobulin and light-chain assays derived from data on biological variation.. Clinical Chemistry. 34(9). 1733–1736. 18 indexed citations
10.
Fraser, C G & M C Browning. (1988). The "index of fiduciality" proposed for use in evaluation and comparison of methods.. Clinical Chemistry. 34(6). 1356–1357. 12 indexed citations
11.
Fraser, C G, et al.. (1987). Biological variation of blood acid-base status: consequences for analytical goal-setting and interpretation of results.. Clinical Chemistry. 33(8). 1416–1418. 10 indexed citations
12.
13.
Callaghan, Samuel J., et al.. (1985). Assessment of the Eppendorf ERIS analyser. Journal of Analytical Methods in Chemistry. 7(2). 90–94. 1 indexed citations
14.
Fraser, C G. (1983). Desirable Performance Standards for Clinical Chemistry Tests. Advances in clinical chemistry. 23. 299–339. 102 indexed citations
15.
Fraser, C G, M J Peake, & G. D. Calvert. (1979). RAPID CHOLESTEROL MEASUREMENT: PATIENT CLASSIFICATION IN HEART RISK EVALUATION CLINICS. The Medical Journal of Australia. 1(10). 465–466. 1 indexed citations
16.
Emmett, Michael, et al.. (1977). THE ANION GAP. The Lancet. 309(8025). 1304–1305. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Janson Breakdown of academic impact, for papers by Marta Stahl Breakdown of academic impact, for papers by Gunn B.B. Kristensen Breakdown of academic impact, for papers by David J. Hassemer Breakdown of academic impact, for papers by Anne Stavelin Breakdown of academic impact, for papers by Marijana Miler Breakdown of academic impact, for papers by Francisco A. Bernabéu-Andréu Breakdown of academic impact, for papers by Solveig Linko Breakdown of academic impact, for papers by Lara Milevoj Kopčinović Breakdown of academic impact, for papers by C. Markus
Rankless by CCL
2026